2024 |
Acelyrin Inc
|
Independent Director |
- |
- |
2024 |
Alumis Inc.
|
Independent Director |
- |
- |
2024 |
Xenon Pharmaceuticals Inc
|
Independent Director |
- |
- |
2024 |
Arcus Biosciences Inc
|
Independent Director |
- |
- |
2024 |
Turnstone Biologics Corp
|
Independent Director |
- |
- |
2023 |
Xenon Pharmaceuticals Inc
|
Independent Director |
559.6 K |
28.2 % |
2023 |
Acelyrin Inc
|
- |
402.2 K |
-41.8 % |
2023 |
Adverum Biotechnologies Inc
|
Chairman of the Board |
163.8 K |
15.8 % |
2023 |
Chimerix Inc
|
Independent Director |
124.5 K |
- |
2023 |
Roivant Sciences Ltd
|
- |
14.2 K |
-98.3 % |
2023 |
Turnstone Biologics Corp
|
Independent Director |
- |
- |
2023 |
Roivant Sciences Ltd
|
Independent Director |
- |
- |
2022 |
Roivant Sciences Ltd
|
Independent Director |
836.6 K |
- |
2022 |
Acelyrin Inc
|
Independent Director |
690.6 K |
- |
2022 |
Xenon Pharmaceuticals Inc
|
Independent Director |
436.3 K |
142.9 % |
2022 |
Arcus Biosciences Inc
|
Independent Director |
371.7 K |
5.5 % |
2022 |
Turnstone Biologics Corp
|
Independent Director |
275.8 K |
- |
2022 |
Adverum Biotechnologies Inc
|
Chairman of the Board |
141.5 K |
-41.4 % |
2022 |
Chimerix Inc
|
Independent Director |
- |
- |
2021 |
Arcus Biosciences Inc
|
Independent Director |
352.3 K |
-14.8 % |
2021 |
Adverum Biotechnologies Inc
|
Chairman of the Board |
241.5 K |
-68.3 % |
2021 |
Chimerix Inc
|
Independent Director |
223.0 K |
66.3 % |
2021 |
Xenon Pharmaceuticals Inc
|
Independent Director |
179.6 K |
10.2 % |
2021 |
Roivant Sciences Ltd
|
Independent Director |
- |
- |
2020 |
Adverum Biotechnologies Inc
|
Chairman of the Board |
762.9 K |
51.4 % |
2020 |
Arcus Biosciences Inc
|
Independent Director |
413.7 K |
47.3 % |
2020 |
Xenon Pharmaceuticals Inc
|
Independent Director |
163.0 K |
- |
2020 |
Chimerix Inc
|
Independent Director |
134.1 K |
1.5 % |
2019 |
Adverum Biotechnologies Inc
|
Chairman of the Board |
504.0 K |
- |
2019 |
Arcus Biosciences Inc
|
Independent Director |
280.8 K |
- |
2019 |
Chimerix Inc
|
Independent Director |
132.2 K |
4.6 % |
2019 |
Scynexis Inc
|
- |
37.3 K |
-48.5 % |
2019 |
Scynexis Inc
|
Independent Director |
- |
- |
2018 |
Chimerix Inc
|
Independent Director |
126.4 K |
0.4 % |
2018 |
Rocket Pharmaceuticals Inc
|
- |
123.7 K |
1.5 % |
2018 |
Scynexis Inc
|
Independent Director |
72.5 K |
-2.2 % |
2018 |
Adverum Biotechnologies Inc
|
Independent Director |
- |
- |
2018 |
Rocket Pharmaceuticals Inc
|
Independent Director |
- |
- |
2017 |
Adverum Biotechnologies Inc
|
Independent Director |
428.2 K |
- |
2017 |
Chimerix Inc
|
Independent Director |
125.8 K |
91.0 % |
2017 |
Rocket Pharmaceuticals Inc
|
Independent Director |
121.8 K |
-10.7 % |
2017 |
Scynexis Inc
|
Independent Director |
74.1 K |
10.9 % |
2016 |
Rocket Pharmaceuticals Inc
|
Independent Director |
136.4 K |
- |
2016 |
Scynexis Inc
|
Independent Director |
66.9 K |
0.3 % |
2016 |
Chimerix Inc
|
Independent Director |
65.9 K |
-75.3 % |
2016 |
Adverum Biotechnologies Inc
|
Independent Director |
- |
- |
2015 |
Chimerix Inc
|
Independent Director |
266.3 K |
-34.7 % |
2015 |
Scynexis Inc
|
Director |
66.7 K |
- |
2014 |
Chimerix Inc
|
Independent Director |
408.0 K |
- |